You are here

Merck

Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS

BioSpace

Fri, 04/5/24 - 11:42 am

clinical trials

KRAS inhibitors

non-small lung cancer

Daiichi Sankyo and Merck dose first subject in ovarian cancer trial

Clinical Trials Arena

Thu, 04/4/24 - 10:53 am

clinical trials

raludotatug deruxtecan

'We're open for business': FDA's Peter Marks says agency ready to review novel cancer vaccines despite unknowns

Fierce Biotech

Wed, 04/3/24 - 10:30 pm

Moderna Therapeutics

EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer

BioSpace

Thu, 03/28/24 - 04:56 pm

non-small cell lung cancer

Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair

Fierce Pharma

Wed, 03/27/24 - 11:22 am

Merck’s next big thing is (probably) on the way

Stat

Tue, 03/26/24 - 11:03 am

Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology

BioSpace

Mon, 03/25/24 - 11:32 am

Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma

Clinical Trials Arena

Thu, 03/21/24 - 06:41 pm

urothelial cancer

Bristol Myers Squibb

Merck combination treatment for lung cancer fails late-stage study

Reuters

Thu, 03/21/24 - 11:13 am

non small cell lung cancer

Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data

BioSpace

Fri, 03/15/24 - 11:28 am

cervical cancer

clinical trials

Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office

Fierce Pharma

Thu, 03/14/24 - 11:29 am

Merck to start trials investigating single dosing regiments of HPV vaccine

Clinical Trials Arena

Wed, 03/13/24 - 10:55 am

clinical trials

Merck bets up to $1B on Pearl's 'smart' biomaterial jewels as biotech begins to raise fresh funds

Fierce Biotech

Tue, 03/12/24 - 11:12 am

ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report

BioSpace

Fri, 03/1/24 - 11:52 am

antibody-drug conjugate

Merck to open new distribution centre in Brazil for Life Science sector

Pharmaceutical Business Review

Wed, 02/28/24 - 10:30 am

Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date

BioSpace

Tue, 02/27/24 - 10:18 am

muscle relaxants

Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster

First Word Pharma

Thu, 02/22/24 - 11:43 am

Samsung Bioepis

clinical trials

Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts

BioPharma Dive

Fri, 02/9/24 - 11:26 am

Bristol Myers Squibb

PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US

Fierce Pharma

Thu, 02/8/24 - 10:08 pm

Bristol Myers Squibb

Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month

Motley Fool

Thu, 02/8/24 - 10:01 pm

Pages